ERYTHEMA NODOSUM LEPROSUM: CONDITION DEVELOPED BY NON-ADHERENCE

Authors

  • EVANGELINE GLADWIN Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India https://orcid.org/0009-0000-9599-3815
  • MUDRA PATEL Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India
  • MANSI MISTRY Department of Pharmacy Practice, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India https://orcid.org/0000-0002-9025-6856

DOI:

https://doi.org/10.22159/ijpps.2024v16i9.51840

Keywords:

Hansen’s disease, Immune-mediated, Type II reaction, Ziel-Neelson stain, Nodules

Abstract

Erythema Nodosum Leprosum (ENL) is a rare immune-mediated complication of leprosy, characterized by painful nodules and fever, and can lead to anemia and leucocytosis. A 19 y old male with a history of non-adherence to 12 adult multi-bacillary multi-drug therapy packs for leprosy presented with a 15 d complaint of fever and aggravated painful, raised, red skin lesions over two y. Laboratory findings showed neutrophilia, thrombocytosis, microcytic anemia, and traces of blood and ketones in the urine. Acid-fast bacilli with a grade of 1+ were observed in Ziel-Neelson-stained smears, confirming the diagnosis. The patient received systemic Dexamethasone, the standard treatment for Erythema Nodosum Leprosum, and resumed leprosy treatment. Symptomatic care was given, and the patient was discharged. This case highlights the importance of early detection, efficient monitoring, and adherence to therapy to reduce ENL-related morbidity and mortality. The study emphasizes that a regular watch should be kept on leprosy patients to ensure early intervention and prevention of complications.

Downloads

Download data is not yet available.

References

Figueroa Diaz A, Cordero Pacheco C, Quintero Noriega A. Erythema nodosum leprosum: a rare cause of testicular nodules. ID Cases. 2023 Jun 16;33:e01823. doi: 10.1016/j.idcr.2023.e01823, PMID 37441582, PMCID PMC10333602.

Voorend CG, Post EB. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLOS Negl Trop Dis. 2013 Oct 3;7(10):e2440. doi: 10.1371/journal.pntd.0002440, PMID 24098819, PMCID PMC3789767.

Bhat RM, Vaidya TP. What is new in the pathogenesis and management of erythema nodosum leprosum. Indian Dermatol Online J. 2020 Jul 13;11(4):482-92. doi: 10.4103/idoj.IDOJ_561_19, PMID 32832433, PMCID PMC7413435.

Jameson JL. Harrison’s manual of medicine. 20th ed. Vol. New York: Mcgraw-Hill Education; 2020. p. 1259-66.

Walker SL, Sales AM, Butlin CR, Shah M, Maghanoy A, Lambert SM. A leprosy clinical severity scale for erythema nodosum leprosum: an international, multicentre validation study of the ENLIST ENL severity scale. PLOS Negl Trop Dis. 2017 Jul 3;11(7):e0005716. doi: 10.1371/journal.pntd.0005716, PMID 28671966, PMCID PMC5510881.

Wankhade VH, Debnath P, Singh RP, Sawatkar G, Bhat DM. A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India. Int J Mycobacteriol. 2019 Jan-Mar;8(1):29-34. doi: 10.4103/ijmy.ijmy_174_18, PMID 30860176.

World Health Organization, WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser. 2012;968:1-61. PMID 22970604.

Leprosy/Hansen disease: management of reactions and prevention of disabilities. Available from: https://iris.who.int/bitstream/handle/10665/332022/9789290227595-eng.pdf?sequence=1 [Last accessed on 21 Aug 2024]

Radha GM, Choudhary M, Ikram A. A retrospective study of histomorphological spectrum of Hansen’s disease in a tertiary care centre of Barabanki area. Asian J Pharm Clin Res. 2023;16(7):71-4.

Mohite RV. Knowledge of slum community toward leprosy: a cross-sectional survey from Karad urban block of Western Maharashtra, India. Asian J Pharm Clin Res. 2018 Mar 1;11(3):357-60.

Zhu J, Shi C, Zhao H, He R, Jing Z, Yang D. Case report: upper thoracic esophageal paralysis accompanying a type 1 leprosy reaction. Am J Trop Med Hyg. 2023 Jun 5;109(2):343-4. doi: 10.4269/ajtmh.22-0799, PMID 37277105, PMCID PMC10397463.

Singal A. Current concepts and challenges in the management of erythema nodosum leprosum. Indian Dermatol Online J. 2020 Jul 13;11(4):479-81. doi: 10.4103/idoj.IDOJ_69_20, PMID 32832432, PMCID PMC7413424.

Sandre MK, Poenaru SM, Boggild AK. Erythema nodosum leprosum triggered by antecedent influenza vaccine and respiratory tract infection: a case report. J Cutan Med Surg. 2019 Jan/Feb;23(1):114-6. doi: 10.1177/1203475418808759, PMID 30326738.

Fachler T, Olshtain Pops K, Horev L. Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemic. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e505-6. doi: 10.1111/jdv.18035, PMID 35224779, PMCID PMC9115004.

Park L, Wallace CE, Vasile G, Buckley C. A case of lepromatous leprosy with erythema nodosum leprosum. Cureus. 2023 Jan 16;15(1):e33846. doi: 10.7759/cureus.33846, PMID 36819324, PMCID PMC9934940.

PK Mishra SR, Samal R, Behera B. Thalidomide and steroid in the management of erythema nodosum leprosum. Indian J Pharmacol. 2022 May-Jun;54(3):177-82. doi: 10.4103/ijp.ijp_946_21, PMID 35848688, PMCID PMC9396689.

Rea TH. Elevated platelet counts and thrombocytosis in erythema nodosum leprosum. Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):167-73. PMID 12483964.

Published

01-09-2024

How to Cite

GLADWIN, E., M. PATEL, and M. MISTRY. “ERYTHEMA NODOSUM LEPROSUM: CONDITION DEVELOPED BY NON-ADHERENCE”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 16, no. 09, Sept. 2024, pp. 40-43, doi:10.22159/ijpps.2024v16i9.51840.

Issue

Section

Case Study(s)